A recent commentary by @igorbandeira.bsky.social et al. highlights the steps in clinical trial design that combine ketamine and naltrexone for major depression, allowing for a mechanistic approach.
@stanfordpsy.bsky.social
#depression #opiod #ketamine #resistantdepression #clinicaltrials
2
0
1
1